qXR-CTR vs Viz AAA
AI Verdict
Choose qXR-CTR if…
Choose qXR-CTR if your primary need is automated, efficient screening for cardiac enlargement and early assessment of heart failure risk using standard chest X-ray images. This tool is ideal for high-volume settings where quick and consistent measurement of the cardiothoracic ratio can aid in identifying patients who may require further cardiac evaluation.
View qXR-CTR →Choose Viz AAA if…
Choose Viz AAA if your priority is the rapid detection, triage, and coordinated management of suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans, especially in emergency or critical care settings. This solution excels at accelerating time-sensitive treatment decisions by providing real-time alerts and facilitating seamless communication among multidisciplinary care teams for a specific vascular pathology.
View Viz AAA →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | qXR-CTR | Viz AAA |
|---|---|---|
| Pricing | Unknown | Enterprise (hospital/health system) |
| Deployment | Can be deployed on cloud or on-premise. The Qure.ai app receives DICOM studies via DICOM network protocol from medical systems (PACS/Modality) or can import DICOM from the local system. The received DICOM study is processed in Qure's cloud server, and AI-processed reports are displayed on the app. | Cloud-based, integrates with PACS and EHR systems. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Viz AAAViz AAA (Tool B) offers a more comprehensive user experience by integrating into existing hospital workflows, providing real-time alerts, and including a HIPAA-compliant communication platform with mobile access. This goes beyond the automated measurement focus of qXR-CTR (Tool A), suggesting a more interactive and workflow-centric design.
Clinical Value
Viz AAABoth tools are FDA-cleared and aim to improve clinical outcomes. However, Viz AAA (Tool B) is highlighted as the 'first FDA-cleared' for its specific application of detecting and triaging suspected Abdominal Aortic Aneurysm, a critical and time-sensitive condition. Its focus on accelerating diagnosis, care coordination, and treatment decisions for such a severe condition suggests a potentially broader and more immediate clinical impact.
Pricing & Value
TieNeither tool provides publicly disclosed pricing, making a direct comparison of their value difficult. While Viz AAA (Tool B) mentions a subscription model based on algorithms and population size, qXR-CTR (Tool A) simply states 'contact for pricing,' leaving both with limited transparency. Without specific cost details, it is impossible to determine which offers better value.
Enterprise Readiness
qXR-CTRBoth tools demonstrate strong enterprise readiness with FDA clearance, HIPAA compliance, and BAA availability. However, qXR-CTR (Tool A) offers more flexible deployment options (cloud, on-premise, hybrid), which can be a significant advantage for enterprises with diverse IT infrastructures or specific data governance requirements.
Innovation
Viz AAAViz AAA (Tool B) stands out for its innovative approach, being the 'first FDA-cleared' solution for AAA detection and triage, indicating a pioneering role in its specific domain. Its features extend beyond simple detection to include automated triage, real-time alerts, and a communication platform, showcasing a more integrated and workflow-transforming innovation.
Support & Docs
qXR-CTRQure.ai (Tool A) provides clear details on its support structure, including a dedicated client success partner, email support with a typical response time of less than 6 hours, and 24/7 availability. Viz.ai (Tool B) also offers customer support and a knowledge base, but Qure.ai's explicit commitment to a dedicated partner and rapid response time suggests a more defined and potentially proactive support system.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | qXR-CTR | Viz AAA |
|---|---|---|
| Name | qXR-CTR | Viz AAA |
| Company | Qure.ai Technologies | Viz.ai |
| Description | qXR-CTR is an AI-powered software by Qure.ai that automates the measurement of the cardiothoracic ratio (CTR) from chest X-ray images, aiding in the assessment of heart size and potential heart failure risk. | Viz AAA is the first FDA-cleared AI-powered solution by Viz.ai for the detection and triage of suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans, designed to accelerate diagnosis and care coordination. |
| Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI, Radiology & Imaging AI, Triage & ER/ICU AI |
| Specialties | Cardiology, Radiology | Emergency Medicine, Radiology, Vascular Surgery |
| Key Features | Not specified | AI-powered automatic detection of suspected AAA from CTA scans, Automated triage and prioritization of cases, Integration into existing hospital workflows, Real-time alerts to care teams, HIPAA-compliant communication platform for multidisciplinary teams, Mobile access to high-fidelity imaging and patient information, Part of the Vizu2122 AORTIC Module for comprehensive aortic pathology solutions, Designed to accelerate treatment decisions and improve patient outcomes |
Videos
Demos, reviews, and walkthroughs featuring qXR-CTR and Viz AAA.